Lung Cancer

sarcoma metastasis to lung :: Article Creator Surviving Stage 4 Lung Cancer: A Personal Story Since then, Ed has worked closely with his care team at the Tampa Moffitt Cancer Center and together they came up with a treatment plan. His healthcare providers decided that Ed would benefit from a three-drug chemotherapy approach. This was because he didn't have an actionable biomarker and targeted therapies weren't an option. Unfortunately, over time the chemotherapy became less effective, so Ed and his oncologist decided to try a Phase One immunotherapy trial. "Both my wife and I were scared. We had young grandchildren and so many things that we wanted to see and do with them. And I was afraid I was going to miss all of that, when chemo stopped working for me." The first clinical trial caused Ed to experience extreme side effects, so he and his oncologist decided to switch to a different Phase One immunotherapy trail, which quickly...

pancreatic survival rate :: Article Creator AI Shown To Predict Risk Of Pancreatic Cancer Well Before Symptoms Appear Scientists have found that artificial intelligence could be an effective tool in predicting pancreatic cancer before a single symptom appears, according to a study published in the journal Nature Medicine on May 8. A team of researchers led by Copenhagen University Hospital in Denmark and Harvard Medical School in Boston completed a sweeping study to determine whether AI could flag a person's risk of developing the disease. The results exceeded their expectations, with the model successfully predicting risk up to three years before diagnosis. PANCREATIC CANCER RATES ARE RISING FASTER AMONG WOMEN THAN MEN: NEW STUDY In 2023, about 64,050 people in the U.S. Will be diagnosed with pancreatic cancer and about 50,550 will die from the aggressive disease, the American Cancer Society (ACS) says. The five-year survi...

multiple myeloma calcium level :: Article Creator How My Training Helps Me To Address Health Disparities In Multiple Myeloma Irene Ghobrial (front, centre, blue dress) leads a multidisciplinary team that addresses health disparities in multiple myeloma at the Dana-Farber Cancer Institute.Credit: Dana-Farber Cancer Institute Irene Ghobrial leads Stand Up To Cancer's Multiple Myeloma Dream Team, which is a part of the research charity that investigates conditions that could lead to this type of bone marrow cancer, which kills 106,000 people annually. Ghobrial, a medical oncologist at the Dana-Farber Cancer Institute and Harvard Medical School, both in Boston, Massachusetts, describes her journey as an immigrant woman of colour to the United States. She explains why translational research is key to advancing personalized treatments and how her team addresses health disparities. What challenges did you face as an early-career researcher after movi...

dr lopez pulmonologist :: Article Creator Cassie Lopez-Jeng Bio:  Dr. Cassie Lopez-Jeng earned her B.S. In Biology from the University of Michigan in 2009, her MPH in Health Education and Communication, and Maternal and Child Health, from Tulane University in 2011, and her Ph.D. In Global Community Health and Behavioral Sciences from Tulane University in 2016. Her research agenda focuses on the intersection of public health and aging, exploring a variety of chronic and aging-specific issues through the lens of health education, including sarcopenia and sarcopenic obesity, patient safety, falls prevention, and women's reproductive health. Recent projects include interdisciplinary falls prevention programs in a variety of healthcare populations and settings. Fun Fact: I played in orchestras for 14 years, including 4 years with the Michigan Pops Orchestra. Dr. Irma Lopez Bio:  Dr. Irma López is a professor in the Department of Spanish and dean...

survival rate of liver cancer :: Article Creator Metastatic Liver Cancer: How Long Can You Live With It And More Cancer that has spread from the liver can be especially aggressive, however, new and better treatments are being developed all the time. Liver cancer is cancer that begins in the liver. If the cancer has metastasized, that means it has spread outside of the liver. The most common form of liver cancer is hepatocellular carcinoma (HCC). This cancer starts in liver cells called hepatocytes. Less common liver cancers include angiosarcomas and hemangiosarcomas. These cancers start in the cells that line the liver's blood vessels. Another type of liver cancer called hepatoblastoma usually affects children under 4 years of age. When cancer starts in the liver, it's considered primary liver cancer. Other types of cancer can spread to the liver, but they're not liver cancer. These are called secondary liver cancers. Sec...

colon staging :: Article Creator 8 Symptoms Of Colon Polyps "Not all colon polyps are cancerous but all colon cancer starts as a polyp which is why everyone needs to know about them and be screened regularly for them," says Fola May, MD, a gastroenterologist and associate professor of medicine, David Geffen School of Medicine at UCLA and the director of Fight Colorectal Cancer. "And colorectal cancer is the second-leading cancer killer of men and women combined." Yikes! OK, we're listening…but what are polyps, exactly? Colon polyps are growths that occur on the inner lining of the large intestine (colon), or the rectum (which comprises the last six inches of the G.I. System before the body expels solid waste). Polyps vary in size and shape, ranging from small, flat bumps to larger, mushroom-shaped growths. Polyps are quite common: It's estimated that 15% to 40% of adults have them, and people who have them generally...